Deep learning enhancing guide RNA design for CRISPR/Cas12a-based diagnostics

Abstract

Rapid and accurate diagnostic tests are fundamental for improving patient outcomes and combating infectious diseases. The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas12a-based detection system has emerged as a promising solution for on-site nucleic acid testing. Nonetheless, the effective design of CRISPR RNA (crRNA) for Cas12a-based detection remains challenging and time-consuming. In this study, we propose an enhanced crRNA design system with deep learning for Cas12a-mediated diagnostics, referred to as EasyDesign. This system employs an optimized convolutional neural network (CNN) prediction model, trained on a comprehensive data set comprising 11,496 experimentally validated Cas12a-based detection cases, encompassing a wide spectrum of prevalent pathogens, achieving Spearman's ρ = 0.812. We further assessed the model performance in crRNA design for four pathogens not included in the training data: Monkeypox Virus, Enterovirus 71, Coxsackievirus A16, and Listeria monocytogenes. The results demonstrated superior prediction performance compared to the traditional experiment screening. Furthermore, we have developed an interactive web server (https://crispr.zhejianglab.com/) that integrates EasyDesign with recombinase polymerase amplification (RPA) primer design, enhancing user accessibility. Through this web-based platform, we successfully designed optimal Cas12a crRNAs for six human papillomavirus (HPV) subtypes. Remarkably, all the top five predicted crRNAs for each HPV subtype exhibited robust fluorescent signals in CRISPR assays, thereby suggesting that the platform could effectively facilitate clinical sample testing. In conclusion, EasyDesign offers a rapid and reliable solution for crRNA design in Cas12a-based detection, which could serve as a valuable tool for clinical diagnostics and research applications.

Keywords

Cas12a / CRISPR / crRNA design / convolutional neural network / deep learning / diagnostic

References

[1] Bouzid, D., M.-C. Zanella, S. Kerneis, B. Visseaux, L. May, J. Schrenzel, and V. Cattoir. 2021. “Rapid Diagnostic Tests for Infectious Diseases in the Emergency Department.” Clinical Microbiology and Infection 27: 182-191. https://doi.org/10.1016/j.cmi.2020.02.024

[2] Gessain, Antoine, Emmanuel Nakoune, and Yazdan Yazdanpanah. 2022. “Monkeypox.” New England Journal of Medicine 387: 1783-1793. https://doi.org/10.1056/NEJMra2208860

[3] Thornhill, John P., Sapha Barkati, Sharon Walmsley, Juergen Rockstroh, Andrea Antinori, Luke B. Harrison, Romain Palich, et al. 2022. “Monkeypox Virus Infection in Humans Across 16 Countries - April-June 2022.” New England Journal of Medicine 387: 679-691. https://doi.org/10.1056/NEJMoa2207323

[4] Ackerman, Cheri M., Cameron Myhrvold, Sri Gowtham Thakku, Catherine A. Freije, Hayden C. Metsky, David K. Yang, Simon H. Ye, et al. 2020. “Massively Multiplexed Nucleic Acid Detection With Cas13.” Nature 582: 277-282. https://doi.org/10.1038/s41586-020-2279-8

[5] Chen, Janice S., Enbo Ma, Lucas B. Harrington, Maria Da Costa, Xinran Tian, Joel M. Palefsky, and Jennifer A. Doudna. 2018. “CRISPR-Cas12a Target Binding Unleashes Indiscriminate Single-Stranded DNase Activity.” Science 360: 436-439. https://doi.org/10.1126/science.aar6245

[6] Wang, Xinjie, Xiaoyun Shang, and Xingxu Huang. 2020. “Next-Generation Pathogen Diagnosis With CRISPR/Cas-Based Detection Methods.” Emerging Microbes & Infections 9: 1682-1691. https://doi.org/10.1080/22221751.2020.1793689

[7] Zetsche, Bernd, Jonathan S. Gootenberg, Omar O. Abudayyeh, Ian M. Slaymaker, Kira S. Makarova, Patrick Essletzbichler, Sara E. Volz, et al. 2015. “Cpf1 Is a Single RNA-guided Endonuclease of a Class 2 CRISPR-Cas System.” Cell 163: 759-771. https://doi.org/10.1016/j.cell.2015.09.038

[8] Mann, James G., and R Jason Pitts. 2022. “PrimedSherlock: A Tool for Rapid Design of Highly Specific CRISPR-Cas12 crRNAs.” BMC Bioinformatics 23: 428. https://doi.org/10.1186/s12859-022-04968-5

[9] Metsky, Hayden C., Nicole L. Welch, Priya P. Pillai, Nicholas J. Haradhvala, Laurie Rumker, Sreekar Mantena, Yibin B. Zhang, et al. 2022. “Designing Sensitive Viral Diagnostics With Machine Learning.” Nature Biotechnology 40: 1123-1131. https://doi.org/10.1038/s41587-022-01213-5

[10] Lee, Minhyeok. 2023. “Deep Learning in CRISPR-Cas Systems: A Review of Recent Studies.” Frontiers in Bioengineering and Biotechnology 11: 1226182. https://doi.org/10.3389/fbioe.2023.1226182

[11] Sapoval, Nicolae, Amirali Aghazadeh, Michael G. Nute, Dinler A. Antunes, Advait Balaji, Richard Baraniuk, C. J. Barberan, et al. 2022. “Current Progress and Open Challenges for Applying Deep Learning Across the Biosciences.” Nature Communications 13: 1728. https://doi.org/10.1038/s41467-022-29268-7

[12] Greener, Joe G., Shaun M. Kandathil, Lewis Moffat, and David T. Jones. 2022. “A Guide to Machine Learning for Biologists.” Nature Reviews Molecular Cell Biology 23: 40-55. https://doi.org/10.1038/s41580-021-00407-0

[13] Kim, Hui Kwon, Seonwoo Min, Myungjae Song, Soobin Jung, Jae Woo Choi, Younggwang Kim, Sangeun Lee, Sungroh Yoon, and Hyongbum (Henry) Kim. 2018. “Deep Learning Improves Prediction of CRISPR-Cpf1 Guide RNA Activity.” Nature Biotechnology 36: 239-241. https://doi.org/10.1038/nbt.4061

[14] Luo, Jiesi, Wei Chen, Li Xue, and Bin Tang. 2019. “Prediction of Activity and Specificity of CRISPR-Cpf1 Using Convolutional Deep Learning Neural Networks.” BMC Bioinformatics 20: 332. https://doi.org/10.1186/s12859-019-2939-6

[15] Poumerol, Gilles, and Annelies Wilder-Smith. 2012. International Travel and Health. Geneva: WHO Press.

[16] OIE. “Manual of Diagnostic Tests and Vaccines for Terrestrial Animals.” Accessed September 20, 2023. https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-manual-online-access/

[17] Wolfe, Nathan D., Claire Panosian Dunavan, and Jared Diamond. 2007. “Origins of Major Human Infectious Diseases.” Nature 447: 279-283. https://doi.org/10.1038/nature05775

[18] Zhou, Peng, Xinglou Yang, Xianguang Wang, Ben Hu, Lei Zhang, Wei Zhang, Haorui Si, et al. 2020. “A Pneumonia Outbreak Associated With a New Coronavirus of Probable Bat Origin.” Nature 579: 270-273. https://doi.org/10.1038/s41586-020-2012-7

[19] Guan, Y., B. J. Zheng, Y. Q. He, X. L. Liu, Z. X. Zhuang, C. L. Cheung, S. W. Luo, et al. 2003. “Isolation and Characterization of Viruses Related to the SARS Coronavirus From Animals in Southern China.” Science 302: 276-278. https://doi.org/10.1126/science.1087139

[20] Wang, Xinjie, Mingtian Zhong, Yong Liu, Peixiang Ma, Lu Dang, Qingzhou Meng, Wenwei Wan, et al. 2020. “Rapid and Sensitive Detection of COVID-19 Using CRISPR/Cas12a-based Detection With Naked Eye Readout, CRISPR/Cas12a-NER.” Science Bulletin 65: 1436-1439. https://doi.org/10.1016/j.scib.2020.04.041

[21] Peck, Kayla M., and Adam S. Lauring. 2018. “Complexities of Viral Mutation Rates.” Journal of Virology 92: e01031-17. https://doi.org/10.1128/JVI.01031-17

[22] Liu, Qiao, Di He, and Lei Xie. 2019. “Prediction of Off-Target Specificity and Cell-Specific Fitness of CRISPR-Cas System Using Attention Boosted Deep Learning and Network-Based Gene Feature.” PLOS Computational Biology 15: e1007480. https://doi.org/10.1371/journal.pcbi.1007480

[23] Palaz, Fahreddin, Ali Kerem Kalkan, Abdullah Tozluyurt, and Mehmet Ozsoz. 2021. “CRISPR-based Tools: Alternative Methods for the Diagnosis of COVID-19.” Clinical Biochemistry 89: 1-13. https://doi.org/10.1016/j.clinbiochem.2020.12.011

[24] Broughton, James P., Xianding Deng, Guixia Yu, Clare L. Fasching, Venice Servellita, Jasmeet Singh, Xin Miao, et al. 2020. “CRISPR-Cas12-based Detection of SARS-CoV-2.” Nature biotechnology 38: 870-874. https://doi.org/10.1038/s41587-020-0513-4

[25] Mills, Margaret G., Kate B. Juergens, Jolene P. Gov, Carter J. McCormick, Reigran Sampoleo, Alisa Kachikis, John K. Amory, et al. 2023. “Evaluation and Clinical Validation of Monkeypox (Mpox) Virus Real-Time PCR Assays.” Journal of Clinical Virology 159: 105373. https://doi.org/10.1016/j.jcv.2022.105373

[26] Li, Xinna, Xinxin Shen, Minghui Li, Juju Qi, Ruihuan Wang, Qingxia Duan, Ruiqing Zhang, et al. 2019. “Applicability of Duplex Real Time and Lateral Flow Strip Reverse-Transcription Recombinase Aided Amplification Assays for the Detection of Enterovirus 71 and Coxsackievirus A16.” Virology Journal 16: 166. https://doi.org/10.1186/s12985-019-1264-z

[27] Cui, Aili, Changping Xu, Xiaojuan Tan, Yan Zhang, Zhen Zhu, Naiying Mao, Yiyu Lu, and Wenbo Xu. 2013. “The Development and Application of the Two Real-Time RT-PCR Assays to Detect the Pathogen of HFMD.” PLoS One 8: e61451. https://doi.org/10.1371/journal.pone.0061451

[28] Burall, Laurel S., Sadra Sepehri, Devayani Srinivasan, Christopher J. Grim, David W. Lacher, Martine Ferguson, Rohini Nambiar, and Atin R. Datta. 2021. “Development and Validation of a Quantitative PCR Method for Species Verification and Serogroup Determination of Listeria Monocytogenes Isolates.” Journal of Food Protection 84: 333-344. https://doi.org/10.4315/JFP-20-178

[29] Huang, Baicheng, Yufeng Lou, Zihan Zeng, Xingchi Kan, Xinping Shi, Yue Wu, Ling Guo et al. 2023. “A Cas12a-based fluorescent microfluidic system for rapid on-site human papillomavirus diagnostics.” Applied Microbiology and Biotechnology 107: 6287-6297. https://doi.org/10.1007/s00253-023-12728-5

RIGHTS & PERMISSIONS

2024 The Authors. iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.